June 10, 2021

ALL SUBSCRIBERS SHOULD HAVE TAKEN NICE GAINS AND EXITED THE OCUGEN POSITION

By Nigam Arora & Dr. Natasha Arora

The Arora Report typically gives target zones with the buy signals.  The first target zone for Ocugen (OCGN) was $7.73 to $8.31.   The stock hit $8 before pulling back.

Per the system, all subscribers should have taken full profits and exited the position or taken partial profits.  Those who were willing to take the risk for the stock to hit the second target zone would have left a small quantity.  Such quantity should have been sold per the system when the stock continued pulling back.

The prior buy zone is no longer valid as this trade is complete.… Please click here or the title below to read more.

Read More

TAKE ADVANTAGE OF A BIG DROP BY BUYING VACCINE MAKER OCUGEN

By Nigam Arora & Dr. Natasha Arora

Editor’s note: In this stock market, there are many opportunities to make significant money not based on fundamentals but with short term trades based on the known behavior of the momo crowd.  Investors should consider taking advantage of such opportunities in addition to long term investments.

The Arora Report provides many such opportunities in addition to the very long term Core Model Portfolio.

This post was just published in ZYX Buy Change Alert.

A NEW IDEA ON COVID VACCINE COMPANY OCGN

Ocugen (OCGN) has a license from an Indian vaccine maker to get the approval of the vaccine in the U.

Please click here or the title below to read more.
Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy